Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2016 - 2025)
Jazz Pharmaceuticals has reported Other Working Capital Changes over the past 16 years, most recently at -$27.5 million for Q4 2025.
- Quarterly Other Working Capital Changes fell 220.35% to -$27.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$29.0 million through Dec 2025, down 231.15% year-over-year, with the annual reading at -$29.0 million for FY2025, 231.15% down from the prior year.
- Other Working Capital Changes was -$27.5 million for Q4 2025 at Jazz Pharmaceuticals, down from -$6.3 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $89.8 million in Q4 2023 and troughed at -$36.3 million in Q1 2025.
- The 5-year median for Other Working Capital Changes is $1.2 million (2021), against an average of $5.2 million.
- Peak annual rise in Other Working Capital Changes hit 1663.9% in 2021, while the deepest fall reached 1715.68% in 2021.
- Tracing JAZZ's Other Working Capital Changes over 5 years: stood at -$21.4 million in 2021, then soared by 157.9% to $12.4 million in 2022, then soared by 623.8% to $89.8 million in 2023, then tumbled by 74.56% to $22.8 million in 2024, then plummeted by 220.35% to -$27.5 million in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$27.5 million, -$6.3 million, and $41.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.